As it awaits the close of its $8.5 billion exit to Goldman Sachs and EQT, Parexel is beefing up its digital strategy with the hire of GlaxoSmithKline's former digital data leader. Stephen Pyke left ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results